DD120192A5 - - Google Patents

Info

Publication number
DD120192A5
DD120192A5 DD187639A DD18763975A DD120192A5 DD 120192 A5 DD120192 A5 DD 120192A5 DD 187639 A DD187639 A DD 187639A DD 18763975 A DD18763975 A DD 18763975A DD 120192 A5 DD120192 A5 DD 120192A5
Authority
DD
German Democratic Republic
Application number
DD187639A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DD120192A5 publication Critical patent/DD120192A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
DD187639A 1974-08-05 1975-08-01 DD120192A5 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2438020A DE2438020A1 (de) 1974-08-05 1974-08-05 18-methyl-19-nor-20-keto-pregnane und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
DD120192A5 true DD120192A5 (en:Method) 1976-06-05

Family

ID=5922668

Family Applications (1)

Application Number Title Priority Date Filing Date
DD187639A DD120192A5 (en:Method) 1974-08-05 1975-08-01

Country Status (17)

Country Link
US (1) US4029777A (en:Method)
JP (1) JPS5141347A (en:Method)
AT (1) AT345998B (en:Method)
BE (1) BE832124A (en:Method)
CA (1) CA1037027A (en:Method)
CH (1) CH611910A5 (en:Method)
CS (2) CS175498B2 (en:Method)
DD (1) DD120192A5 (en:Method)
DE (1) DE2438020A1 (en:Method)
DK (1) DK136369C (en:Method)
ES (1) ES439720A1 (en:Method)
FR (1) FR2281123A1 (en:Method)
GB (1) GB1512258A (en:Method)
HU (1) HU171684B (en:Method)
IL (1) IL47770A (en:Method)
NL (1) NL7509326A (en:Method)
SE (1) SE404804B (en:Method)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61144199A (ja) * 1984-12-18 1986-07-01 Pioneer Electronic Corp スピ−カ用紙製振動部材の製造方法
WO1989002272A1 (en) * 1987-08-25 1989-03-23 Gee Kelvin W Compositions and methods for alleviating stress, anxiety and seizure activity
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
US5175154A (en) * 1987-11-25 1992-12-29 Research Corporation Technologies, Inc. 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
MX395023B (es) 2013-04-17 2025-03-24 Sage Therapeutics Inc Esteroides c21-n-pirazolilo 19-nor c3,3-disustituidos y metodos de uso de los mismos.
PT2986624T (pt) 2013-04-17 2020-07-07 Sage Therapeutics Inc Esteroides neuroativos 19-nor para métodos de tratamento
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
RU2754534C2 (ru) 2013-07-19 2021-09-03 Сейдж Терапьютикс, Инк. Нейроактивные стероиды, композиции и их использование
BR112016003862B1 (pt) 2013-08-23 2022-09-06 Sage Therapeutics, Inc Compostos esteroides neuroativos, suas composições e seus usos
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
US20170233433A1 (en) 2014-10-16 2017-08-17 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
CN107404877A (zh) 2014-10-16 2017-11-28 萨奇治疗股份有限公司 靶向cns 障碍的组合物和方法
HRP20200840T1 (hr) 2014-11-27 2020-11-13 Sage Therapeutics, Inc. Pripravci i postupci za liječenje poremećaja cns-a
HUE054092T2 (hu) 2015-01-26 2021-08-30 Sage Therapeutics Inc Központi idegrendszeri zavarok kezelésére szolgáló kompozíciók és eljárások
US10329320B2 (en) 2015-02-20 2019-06-25 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
CA3030420A1 (en) 2016-07-11 2018-01-18 Sage Therapeutics, Inc. C7, c12, and c16 substituted neuroactive steroids and their methods of use
EP4302764A3 (en) 2016-07-11 2024-06-26 Sage Therapeutics, Inc. C17, c20, and c21 substituted neuroactive steroids and their methods of use
DK3728284T3 (da) * 2017-12-22 2024-10-28 Sage Therapeutics Inc 19-homo, 3.alpha.-hydroxy-steroid-20-on forbindelser til behandling af cns-lidelser
JOP20210293A1 (ar) 2019-05-31 2023-01-30 Sage Therapeutics Inc ستيرويدات ذات فعالية عصبية وتركيبات منها

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791196A (fr) * 1971-11-11 1973-05-10 Glaxo Lab Ltd Nouveaux steroides, leur procede de preparation et leurs applications
GB1409239A (en) * 1971-11-11 1975-10-08 Glaxo Lab Ltd Process for the preparation of 3alpha-hydroxy-5alpha-steroids

Also Published As

Publication number Publication date
AU8351575A (en) 1977-02-03
SE404804B (sv) 1978-10-30
CH611910A5 (en:Method) 1979-06-29
DK344475A (da) 1976-02-06
DK136369C (da) 1978-02-27
CS175500B2 (en:Method) 1977-05-31
BE832124A (fr) 1976-02-05
ES439720A1 (es) 1977-03-01
DK136369B (da) 1977-10-03
ATA600475A (de) 1978-02-15
CS175498B2 (en:Method) 1977-05-31
AT345998B (de) 1978-10-10
FR2281123A1 (fr) 1976-03-05
IL47770A0 (en) 1975-10-15
GB1512258A (en) 1978-05-24
HU171684B (hu) 1978-02-28
NL7509326A (nl) 1976-02-09
IL47770A (en) 1978-10-31
CA1037027A (en) 1978-08-22
DE2438020A1 (de) 1976-02-26
JPS5141347A (en) 1976-04-07
SE7508777L (sv) 1976-02-06
US4029777A (en) 1977-06-14

Similar Documents

Publication Publication Date Title
AU495883B2 (en:Method)
AU7459074A (en:Method)
AU486824B2 (en:Method)
AU495870B2 (en:Method)
AU7474774A (en:Method)
AU7465874A (en:Method)
AR197698Q (en:Method)
AR198841Q (en:Method)
AU8476175A (en:Method)
BG19722A1 (en:Method)
BG19893A1 (en:Method)
AU480925A (en:Method)
AU481082A (en:Method)
AU481479A (en:Method)
AU481765A (en:Method)
AU482043A (en:Method)
AU482115A (en:Method)
AU482149A (en:Method)
AU480209A (en:Method)
AU479870A (en:Method)
AU482294A (en:Method)
AU7253373A (en:Method)
BE836321A (en:Method)
BG19670A1 (en:Method)
AU479427A (en:Method)